Concepedia

TAISUKE INAGAKI

TI

13

Publications

605

Citations

12

H-Index

1987

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (Japan)

Meijo University

Institute of Applied Biochemistry

TAISUKE INAGAKI is an author at Pfizer (United States) specializing in biochemistry, vascular biology, and atherosclerosis.

Top concepts

Publications per year

1987–2002

13

Publications

13

A New Antibiotic CJ-17,665 from Aspergillus ochraceus.

Yutaka Sugie, Hideo Hirai, TAISUKE INAGAKI et al. · The Journal of Antibiotics · 2001 · 100 citations · Full text

Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum.

Toshiyuki Saito, FUKUMATSU AOKI, Hideo Hirai et al. · The Journal of Antibiotics · 1998 · 72 citations · Full text

New Quinolone Compounds from Pseudonocardia sp. with Selective and Potent Anti-Helicobacter pylori Activity: Taxonomy of Producing Strain, Fermentation, Isolation, Structural Elucidation and Biological Activities.

Koen Dekker, TAISUKE INAGAKI, Thomas D. Gootz et al. · The Journal of Antibiotics · 1998 · 68 citations · Full text

CJ-12,371 and CJ-12,372, Two Novel DNA Gyrase Inhibitors. Fermentation, Isolation, Structural Elucidation and Biological Activities.

Shinichi Sakemi, TAISUKE INAGAKI, KEIJI KANEDA et al. · The Journal of Antibiotics · 1995 · 58 citations · Full text

CJ-12,954 and Its Congeners, New Anti-Helicobacter pylori Compounds Produced by Phanerochaete velutina:Fermentation, Isolation, Structural Elucidation and Biological Activities.

Koen Dekker, TAISUKE INAGAKI, Thomas D. Gootz et al. · The Journal of Antibiotics · 1997 · 58 citations · Full text

Rows per page

1–5 of 13